E1	Condition:T1 Name:T50
E2	Age:T2 Eq-Comparison:E3
E3	Eq-Comparison:T3 Value:T51 Operator:T52 Value:T53 Temporal-Unit:T54
E5	Eq-Comparison:T5 Temporal-Period:T55
E6	Procedure:T6 Temporality:E5
E7	Drug:T7 Name:T56
E8	Or:T8 Arg:E7 Arg2:E9
E9	Drug:T9 Name:T57
E10	Procedure:T10 Name:T58
E11	Condition:T11 Name:T59
E12	Risk:T12 Polarity:T60 Risk-For:E15
E13	Or:T13 Arg:E12 Arg2:E14
E14	Risk:T14 Polarity:T61 Risk-For:E15
E15	Condition:T15 Name:T63 Severity:T62
E16	Condition:T16 Name:T65 Severity:T64
E17	Condition:T17 Name:T66
E18	Modifier:T18 Modifies:T67
E19	Condition:T19 Name:T67
E20	Condition:T20 Name:T68
E21	Condition:T21 Name:T69
E22	Condition:T22 Name:T70
E23	Age:T23 Eq-Comparison:E24
E24	Eq-Comparison:T24 Value:T72 Operator:T73 Value:T74 Temporal-Unit:T75
E25	Condition:T25 Name:T76
E26	Or:T26 Arg:E25 Arg2:E28
E28	Condition:T28
E29	Assertion:T29 Asserted:T77 Asserted2:T78
E30	Or:T30 Arg:T77 Arg2:T78
E31	Study:T31 Stability:T78
E32	Condition:T32 Name:T79
E35	Assertion:T35 Asserted:T81
E36	Observation:T36 Name:T27 Stability:T81
E37	Observation:T37 Specimen:T82
E39	Procedure:T39 Name:T33
E40	Condition:T40 Name:T83
E41	Eq-Comparison:T41 Temporal-Period:T84
E42	Procedure:T42 Name:T85 Temporality:E41
E43	Negation:T43 Negates:E42
E44	Condition:T44 Name:T86
E46	Or:T46 Arg:T87 Arg2:E47
E47	Modifier:T47 Modifies:T88
E48	Condition:T48 Name:T88 Severity:T87
E49	Negation:T49 Negates:E48
E4	And:T4 Arg:E2 Arg2:E6
E50	Negation:T90 Negates:E18
E51	Negation:T91 Negates:E25 Negates2:E28
E52	And:T92 Arg:E23 Arg2:E51
T1	Condition 43 41	cancer
T2	Age 57 55	age
T3	Eq-Comparison 72 66	1-18 years
T5	Eq-Comparison 89 83	received
T6	Procedure 109 103	treatment
T7	Drug 138 132	anthracycline
T8	Or 147 139	and/or
T9	Drug 164 156	alkylating agent
T10	Procedure 177 169	chemotherapy
T11	Condition 194 184	Diseases
T12	Risk 237 226	risk
T13	Or 240 229	or
T14	Risk 255 244	risk
T15	Condition 284 273	lymphoblastic leukemia
T16	Condition 309 297	myeloid leukemia
T17	Condition 328 315	Hodgkin lymphoma
T18	Modifier 344 328	Hodgkin
T19	Condition 353 337	lymphoma
T20	Condition 364 347	sarcomas
T21	Condition 375 356	Healthy
T22	Condition 397 376	Healthy
T23	Age 435 414	ages
T24	Eq-Comparison 450 425	1-18 years
T25	Condition 481 456	diseases
T26	Or 484 459	or
T28	Condition 503 478	medical conditions
T29	Assertion 517 492	might be
T30	Or 532 507	or
T31	Study 570 545	study
T32	Condition 581 554	Healthy
T35	Assertion 728 696	can
T36	Observation 760 728	epigenetic signature
T37	Observation 818 784	blood
T39	Procedure 854 820	routine care
T40	Condition 886 848	Cancer
T41	Eq-Comparison 928 888	received
T42	Procedure 953 913	bone marrow transplant
T43	Negation 962 922	not
T44	Condition 985 943	Healthy
T46	Or 1095 1047	or
T47	Modifier 1103 1055	chronic
T48	Condition 1111 1063	disease
T49	Negation 1128 1080	excluded
T50	Condition-Name 43 41	cancer
T51	Eq-Value 60 57	1
T52	Eq-Operator 62 58	-
T53	Eq-Value 66 60	18
T54	Eq-Temporal-Unit 72 66	years
T55	Eq-Temporal-Period 89 83	received
T56	Drug-Name 138 132	anthracycline
T57	Drug-Name 164 156	alkylating agent
T58	Procedure-Name 177 169	chemotherapy
T59	Condition-Name 194 184	Diseases
T60	Polarity 232 221	high
T61	Polarity 250 239	high
T62	Severity 261 250	acute
T63	Condition-Name 284 273	lymphoblastic leukemia
T64	Severity 292 280	acute
T65	Condition-Name 309 297	myeloid leukemia
T66	Condition-Name 328 315	Hodgkin lymphoma
T67	Condition-Name 353 337	lymphoma
T68	Condition-Name 364 347	sarcomas
T69	Condition-Name 375 356	Healthy
T70	Condition-Name 397 376	Healthy
T71	Life-Stage-And-Gender 430 409	children
T72	Eq-Value 438 416	1
T73	Eq-Operator 440 417	-
T74	Eq-Value 444 419	18
T75	Eq-Temporal-Unit 450 425	years
T76	Condition-Name 481 456	diseases
T77	Stability 526 501	affected
T78	Stability 547 522	impact
T79	Condition-Name 581 554	Healthy
T81	Stability 735 703	affect
T82	Observation-Specimen 818 784	blood
T83	Condition-Name 886 848	Cancer
T84	Eq-Temporal-Period 928 888	received
T85	Procedure-Name 953 913	bone marrow transplant
T86	Condition-Name 985 943	Healthy
T87	Severity 1092 1044	acute
T88	Condition-Name 1111 1063	disease
T89	Life-Stage-And-Gender 36 34	Childhood
T4	And 80 74	who
T90	Negation 334 320	non
T91	Negation 472 447	free from
T92	And 458 433	who
T27	Observation-Name 760 728	epigenetic signature
T33	Procedure-Name 854 820	routine care
A1	Assertion-Type-Value E29 hypothetical
A3	Assertion-Type-Value E35 hypothetical
A4	Eq-Operator-Value T52 BETWEEN
A5	Eq-Temporal-Unit-Value T54 year
A6	Eq-Temporal-Period-Value T55 past
A7	Polarity-Value T60 high
A8	Polarity-Value T61 high
A9	Severity-Value T62 severe
A10	Severity-Value T64 severe
A11	Life-Stage-And-Gender-Type T71 child
A12	Eq-Operator-Value T73 BETWEEN
A13	Eq-Temporal-Unit-Value T75 year
A14	Stability-Value T77 change
A15	Stability-Value T78 change
A16	Stability-Value T81 change
A17	Eq-Temporal-Period-Value T84 past
A18	Severity-Value T87 severe
A19	Life-Stage-And-Gender-Type T89 child
R1	Using Arg1:E6 Arg2:E7
R2	Using Arg1:E10 Arg2:E7
R3	Using Arg1:E10 Arg2:E9
R4	Example-Of Arg1:E15 Arg2:E11
R5	Example-Of Arg1:E16 Arg2:E11
R6	Example-Of Arg1:E17 Arg2:E11
R7	Example-Of Arg1:E19 Arg2:E11
R8	Example-Of Arg1:E20 Arg2:E11
R9	Equivalent-To Arg1:T71 Arg2:E22
R10	Caused-By Arg1:T78 Arg2:E25
R11	Caused-By Arg1:T78 Arg2:E28
R12	Using Arg1:E39 Arg2:E37